Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ichiro Yoshino, MD, PhD"'
Autor:
Shigehiro Yagishita, MD, PhD, Yasushi Goto, MD, PhD, Makoto Nishio, MD, PhD, Hiroaki Akamatsu, MD, PhD, Hidetoshi Hayashi, MD, PhD, Satoru Miura, MD, PhD, Koji Tamada, MD, PhD, Hiroshi Kagamu, MD, PhD, Akinobu Hamada, PhD, Mayu Ohuchi, PhD, Akihiko Gemma, MD, PhD, Ichiro Yoshino, MD, PhD, Toshihiro Misumi, PhD, Akito Hata, MD, Satoshi Hara, MD, Takashi Kijima, MD, PhD, Fujita Masaki, MD, PhD, Shunichiro Iwasawa, MD, PhD, Shintaro Nakagawa, MSc, Masahiro Tatsuno, MSc, Tetsuya Mitsudomi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 7, Pp 100683- (2024)
Introduction: This study validated real-world pharmacokinetic (PK) data using an established population PK (PopPK) model for atezolizumab in Japanese patients with NSCLC and explored the relationship between PK parameters, effectiveness, and adverse
Externí odkaz:
https://doaj.org/article/5313a5b432ab4c3892187d0d69ddf659
Autor:
Satoru Miura, MD, PhD, Makoto Nishio, MD, PhD, Hiroaki Akamatsu, MD, PhD, Yasushi Goto, MD, PhD, Hidetoshi Hayashi, MD, PhD, Akihiko Gemma, MD, PhD, Ichiro Yoshino, MD, PhD, Toshihiro Misumi, PhD, Akito Hata, MD, Osamu Hataji, MD, PhD, Kohei Fujita, MD, PhD, Masahiro Seike, MD, PhD, Noriko Yanagitani, MD, PhD, Kazumi Nishino, MD, PhD, Satoshi Hara, MD, Ryota Saito, MD, PhD, Masahide Mori, MD, PhD, Takeshi Tsuda, MD, Shunichiro Iwasawa, MD, PhD, Shintaro Nakagawa, MSc, Tetsuya Mitsudomi, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 3, Pp 100484- (2023)
Introduction: The efficacy and safety of atezolizumab in previously treated patients with NSCLC have been established in the registrational phase 3 OAK trial. In this study, we evaluated the effectiveness and safety of atezolizumab monotherapy in a l
Externí odkaz:
https://doaj.org/article/cf2603aadeec484c8f8d98e2ec1d639b
Autor:
Kenji Sugio, MD, PhD, FACS, Tatsuro Okamoto, MD, PhD, Yoshimasa Maniwa, MD, PhD, Yasushi Toh, MD, PhD, Morihito Okada, MD, PhD, Taku Yamashita, MD, PhD, Shogo Shinohara, MD, PhD, Ichiro Yoshino, MD, PhD, Masayuki Chida, MD, PhD, Hiroyuki Kuwano, MD, PhD, Akihiro Shiotani, MD, PhD
Publikováno v:
JTCVS Open, Vol 8, Iss , Pp 633-647 (2021)
Objective: We aimed to clarify the clinical features and surgical outcomes of descending necrotizing mediastinitis (DNM) to provide a guide for its surgical treatment, focusing on the type of extension and the deployed procedures. Methods: As a joint
Externí odkaz:
https://doaj.org/article/c12dac40859f42bbbad83038e6f18d5b
Autor:
Yuichi Ozawa, MD, PhD, Nobuyuki Yamamoto, MD, PhD, Kouji Yamamoto, PhD, Kentaro Ito, MD, Hirotsugu Kenmotsu, MD, PhD, Hidetoshi Hayashi, MD, PhD, Takehito Shukuya, MD, PhD, Daichi Fujimoto, MD, PhD, Shunichi Sugawara, MD, PhD, Seiji Niho, MD, PhD, Yuichiro Ohe, MD, PhD, Hiroaki Okamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD, Katsuyuki Kiura, MD, PhD, Ichiro Yoshino, MD, PhD, Akihiko Gemma, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 3, Iss 5, Pp 100317- (2022)
Introduction: Although data accumulated in clinical trials have higher accuracy compared with real-world data and are irreplaceably valuable, most previous clinical trial data have been left unused. Methods: The Japan Lung Cancer Society (JLCS) asked
Externí odkaz:
https://doaj.org/article/cf2d0ca2ab7547e2abd79d3f7eb16898